.K.C.h...C...ren

Size: px
Start display at page:

Download ".K.C.h...C...ren"

Transcription

1 1 1, Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al: Tajimi Study Group, Japan Glaucoma Society: The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology , Yamamoto T, Iwase A, Araie M, Suzuki Y, Abe H, Shirato S, et al: Tajimi Study Group, Japan Glaucoma Society: The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology , 2005.

2 van Herick 60 Grade 1 1/4 Grade 2 1/4 Grade 3 1/4 1/2 Grade 4 Shaffer Grade 00 Grade 110 Grade 2 20 Grade Scheie Grade 0 Grade Grade Grade Grade Humphery 1 3 1

3 Glaucoma Hemifield Test 1 Anderson DR, Patella VM: Automated Static Perimetry. 2nd edtion, Mosby, St. Louis, , 1999.

4 1 2 a b Goldmann GP a GP b GP a GP 4 1/4 b GP 4 1/4 1/2 GP 4 1/2 a GP 4 b GP 4 GP 4 Aulhorn Greve 3 Stage db Mariotte 6 db Stage 1 10 db Mariotte Stage 2Mariotte Stage 3 Mariotte Stage 4 1 Stage 5

5 1 Stage 6 Humphery 4 6 db db 1 12 db db 5 15 db Greve EL, Langerhorst CT, van den Berg TTJP: Perimetry and other visual function tests in glaucoma. In Cairns JE ed : Glaucoma. Vol. 1. Grune & Stratton, London, 37 77, 1986.

6 4 Anderson DR. Patella VM: Automated Static Perimetry. 2nd edition. Mosby, St. Louis, , 1999.

7 Schlemm

8 1 1

9

10

11 Schlemm

12 Parkinson

13 ,000 mg

14 ,000 mg Stevens-Johnson Lyell Addison QT

15 ACTH D 20 D 15 D10 15 D5 D 5 15 ml/kg g D g

16 50 3 ml/kg ml

17 ml

18

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc 4 54 55 56 ( ( 1994 1st stage 2nd stage 2012 57 / 58 365 46.6 120 365 40.4 120 13.0 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 4 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97

More information

緑内障診療ガイドライン(第3版)

緑内障診療ガイドライン(第3版) 36 日眼会誌 116 巻 1 号 補足資料 1 1)2). 日本における緑内障有病率 病型 男性 女性 全体 GradeⅢ: 線維柱帯の後方半分が観察できない GradeⅣ: 隅角のすべての部位が観察できない 原発開放隅角緑内障 ( 広義 ) 原発開放隅角緑内障 正常眼圧緑内障 原発閉塞隅角緑内障 続発緑内障 早発型発達緑内障 全緑内障 4.1(3.0-5.2) 0.3(0.0-0.7) 3.7(2.7-4.8)

More information

橡アロマセラピー症状別処方例.PDF

橡アロマセラピー症状別処方例.PDF 1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

More information

取扱説明書

取扱説明書 ED-601 ED-501 ED-401 2 3 4 23 14 5 6 18 10 7 1 2 6 3 4 8 9 16 16 16 12 1 2 18 10 2 1 5 12 11 1 2 1 2 12 1 2 13 16 14 3 2 4 1 1 2 16 3 4 18 15 1 2 16 2 3 1 1 2 3 18 17 18 22 19 D A C 20 A B 22 B C D 22

More information

untitled

untitled 5 2009 MAY Public relations OZU 2009 5 Vol.1 C o n t e n t s P3 P2 P6 P10 P14 P16 P18 P20 P22 P24 P26 P28 P32 P34 2 3 4 5 Q Q A Q A Q A Q A Q A Q A Q A Q A A 21 7 6 9 8 10 11 12 13 14 15 2009 ALL JAPAN

More information

EPSON

EPSON B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &

More information

2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1

2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7

More information

bumon_pro.indd

bumon_pro.indd q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2

More information

‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q

‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

More information

2012_05_GLK_cover.indd

2012_05_GLK_cover.indd c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A

More information

™…

™… 2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10

More information

JSI Newsletter

JSI Newsletter The Japanese Society for Immunology Newsletter URL;http://jsi.bcasj.or.jp/newpage1.htm C O N T E N T S 2 VOL.7 NO.2 VOL.7 NO.2 3 4 VOL.7 NO.2 VOL.7 NO.2 5 6 VOL.7 NO.2 VOL.7 NO.2 7 8 VOL.7 NO.2 VOL.7 NO.2

More information

みさき_1

みさき_1 2 3 4 5 6 7 1F 2F 8 9 10 11 17 18 19 20 21 22 23 24 31 25 26 27 28 29 30 8 1 2 3 4 5 6 7 6 8 7 16 7 8 9 10 11 12 14 15 13 17 23 Vol.41 8 6 20 11 7 15 7 23 7 7 7 16 23 23 8 13 18:00 22:00 722

More information

H21_report

H21_report vol.4 1 2 6 10 14 18 20 22 24 25 1 2 2172 73 3 21925 926 21125 126 4 5 6 21629 630 7 21107 108 21127 128 8 9 10 21616 617 11 211026 1027 211213 1214 12 13 14 21713 714 15 2194 95 211031 111 16 17 18 19

More information

2009-9-2.indd

2009-9-2.indd Q No.1441 Q No.1442 Vol.33 NO.9 (2009) 30 (614) Q No.1443 Vol.33 NO.9 (2009) 31 (615) Q No.1444 Vol.33 NO.9 (2009) 32 (616) Vol.33 NO.9 (2009) 33 (617) Vol.33 NO.9 (2009) 34 (618) Q No.1445 Vol.33 NO.9

More information

untitled

untitled Vol.27 1 Vol.27 2 Vol.27 3 Vol.27 4 Vol.27 5 Vol.27 6 Vol.27 7 Vol.27 8 Vol.27 9 Vol.27 10 11 Vol.27 Vol.27 12 Vol.27 13 Vol.27 14 Vol.27 15 Vol.27 16 Vol.27 17 Vol.27 2007 10 29 18 http://www.nira.or.jp/index.html

More information

09030549_001.図書館31-1

09030549_001.図書館31-1 vol.31 NO.1 2 3 5 6 10 12 8 1947-1954- 1950-1838-1904 1952-1996 1 913-1954 1981-1958- 1 902-1992 1972-1946- 1 940- 1 2 3 3 5 6 6 8 8 12 8 8 1 2 2 http://library.hokkai-s-u.ac.jp/cgi-bin/tosyokan/index.cgi

More information